Status:
ENROLLING_BY_INVITATION
Truway Diagnostic Tools in Primary Care
Lead Sponsor:
Truway Health, Inc.
Conditions:
Chronic Disease
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
This study evaluates the effectiveness of Truway Health-sourced portable diagnostic devices, including ultrasound and blood glucose monitors, in early detection of chronic conditions in outpatient pri...
Detailed Description
This prospective interventional study, titled "Evaluation of Truway Health-Sourced Portable Diagnostic Devices for Early Detection of Chronic Conditions in Outpatient Primary Care Settings," is design...
Eligibility Criteria
Inclusion
- Age 18 to 75 years, inclusive
- Ability to understand the study procedures and provide written informed consent
- Diagnosis of the target condition according to established clinical or diagnostic criteria
- Stable treatment regimen (pharmacologic or non-pharmacologic) for at least 4 weeks prior to screening
- Willingness and ability to comply with all study visits, procedures, and follow-up assessments -
Exclusion
- Pregnancy or breastfeeding at the time of enrollment
- Known hypersensitivity to any components of the investigational intervention
- Uncontrolled or unstable comorbid conditions (for example, cardiovascular, hepatic, renal, or psychiatric disorders)
- Participation in another interventional clinical trial within the past 3 months
- Cognitive impairment or language barrier that would preclude valid informed consent or reliable reporting
- \-
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07209527
Start Date
October 1 2025
End Date
October 1 2028
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Truway Health, Inc.
New York, New York, United States, 10016